ACT-1016-0707 is a potent, selective, and insurmountable lysophosphatidic acid receptor 1 (LPA1) antagonist,ACT-1016-0707 demonstrates pronounced antifibrotic and anti-inflammatory activities in experimental models. ACT-1016-0707 has been studied extensively in vitro and in vivo lung fibrosis models, where it reduces pathological fibrotic progression, thereby representing a candidate compound for research into fibrotic lung diseases.
Molecular Weight:
438.93
Purity:
99.90%
CAS Number:
[2569467-78-1]
Formula:
C19H23ClN4O4S
Target:
LPL Receptor|||LPA Receptor
T85589
* VAT and and shipping costs not included. Errors and price changes excepted
